内部人交易记录
董事尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Brege Laura, 董事. Insider active across 3 companies, notably Pacira BioSciences, Inc.. Aggregated, 19 filings have been logged. Split: 1 buy · 4 sells. Total volume traded: €625k. History available since 9 June 2021. The latest transaction was disclosed on 11 September 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Brege Laura
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报19 总计
6,405 股Common StockSEC:0001628280-26-043002:0
8,107 股Common StockSEC:0001365619-26-000002:0
17,000 股@ US$15.00100.0% 占其流量Common StockSEC:0001415889-25-024463:0
6,163 股0Common StockSEC:0001396814-25-000080:0
14,446 股@ US$21.7834.9% 占其流量Common StockSEC:0001415889-25-015832:0
5,703 股Common StockSEC:0001415889-25-015303:0
9,387 股Common StockSEC:0001415889-25-015270:0
1,000 股@ US$12.815.2% 占其流量Common StockSEC:0001396814-24-000117:0
5,230 股0Common StockSEC:0001396814-24-000073:0
6,652 股Common StockSEC:0001415889-24-015084:0
1,775 股0Common StockSEC:0001209191-23-038014:0
4,500 股@ US$24.86820.3% 占其流量Common StockSEC:0001209191-23-037106:0
600 股@ US$38.749.6% 占其流量Common StockSEC:0001209191-23-035254:0
3,059 股Common StockSEC:0001209191-23-034697:0
7,000 股@ US$29.9085.2% 占其流量Common StockSEC:0001209191-23-023336:0
12,500 股@ US$17.0138.5% 占其流量Common StockSEC:0001209191-23-003554:0
12,500 股@ US$18.2541.3% 占其流量Common StockSEC:0001209191-23-003554:1
1,160 股0Common StockSEC:0001209191-22-035215:0
1,066 股0Common StockSEC:0001209191-21-040079:0
About Brege Laura
Brege Laura is Administrateur at Pacira BioSciences, Inc., Acadia Pharmaceuticals INC and Mirum Pharmaceuticals, Inc. She has 19 filings in total, and across the 19 sampled filings the buy amounts are EUR 11674 and the sell amounts are EUR 613028, covering the period from 2021-06-11 to 2026-06-12. The most common transaction nature is Levée d'options.